Results 201 to 210 of about 281,298 (260)

FBXW7 suppresses cell proliferation, migration, and epithelial-mesenchymal transition in endometrioid ovarian carcinoma. [PDF]

J Cancer
Tsai CC, Hsu CY, Suen JL, Tu HP, Tsai KB, Huang SC, Ou YC, Tsai EM.   +7 more
europepmc   +1 more source

Multi‐omics–driven precision medicine

iMeta, EarlyView.
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li, Zhe Zhao, Yifan Zhang, Yao Ma, Gaofei Hu, Min Zeng, Zhanqun Yang, Zixuan Zhao, Xin Zhou, Wei Hu, Yuxuan Sun, Meng Su, Jun Li, Matthew Whiteman, Wei Fu, Chao Zhong, Lemin Zheng, Long Chen, Hairong Lv, Rongsheng Zhao, Yi Zhun Zhu   +20 more
wiley   +1 more source

Two-staged CT-based radiomics model in characterising early-stage ovarian carcinoma and benign ovarian masses. [PDF]

J Ovarian Res
Zhang J, Singh R, Wong EMF, Han L, Ho G, Chiu WHK, Cho IMK, Ip PPC, Lee EYP.   +8 more
europepmc   +1 more source

Synchronous triple cancers of synchronous endometrial and ovarian carcinoma complicated by renal cancer: a case report. [PDF]

Front Oncol
Xu M, Fu J, Cai L.
europepmc   +1 more source

Comparison of Peritoneal Carcinomatosis Scoring Methods to Assess Resectability in Ovarian Carcinoma. [PDF]

Cureus
Sebastian JA, Bandegudda S, Muralidhar KB.   +2 more
europepmc   +1 more source

Prognostic and Predictive Significance of Claudin-6 Expression in Advanced-Stage High-Grade Serous Ovarian Carcinoma. [PDF]

Diagnostics (Basel)
Demir T, Kefeli M, Aydoğan Demir AR, Uygun FN, Akpunar M, Tekce Yıldız E, Demirağ G.   +6 more
europepmc   +1 more source

Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian Carcinoma. [PDF]

Cells
Lightfoot M, Dorayappan KDP, Vudatha V, Chakrapani LN, Das P, Yu L, Hisey C, Sakaue T, Muthusamy T, Panneerselvam P, Backes F, Cosgrove C, Hansford D, Cohn DE, O'Malley DM, Gogna R, Selvendiran K.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mucinous Ovarian Carcinoma

New England Journal of Medicine, 2019
(Abstracted from N Engl J Med 2019;380:1256–1266) Mucinous ovarian cancer is a rare form of epithelial ovarian cancer, accounting for approximately 3% of all cases. New understanding of the biological features of this unique disease requires an update to traditional diagnostic and therapeutic protocols that have been historically based on ...
Morice, Philippe, Gouy, Sebastien, Leary, Alexandra   +2 more
openaire   +5 more sources

Hereditary ovarian carcinoma

Seminars in Surgical Oncology, 1994
AbstractOvarian cancer is the leading cause of death from gynecologic cancer in the united states. Although the etiology of ovarian cancer is unknown, a number of factors including advancing age, nulliparity and environmental factors have traditionally been related to risk.
H H, Gallion, S A, Smith
openaire   +2 more sources

Epithelial ovarian carcinoma

The Lancet, 1997
The low survival rate is related to the high proportion of women who have spread of disease beyond the ovaries at diagnosis—25%, 11%, 47%, and 17% of cases at stage I‐IV, respectively, according to International Federation of Gynaecological and Obstetrics (FIGO) staging ...
G B, Kristensen, C, Tropé
openaire   +2 more sources